- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BeyondSpring Inc (BYSI)
BeyondSpring Inc stock price live, this page displays NASDAQ BYSI stock exchange data. View the BYSI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BeyondSpring Inc real time stock price chart below.
What Is the BeyondSpring Inc Stock Price Today?
The BeyondSpring Inc stock price today is 1.550.
What Is the Stock Symbol for BeyondSpring Inc?
The stock symbol for BeyondSpring Inc is "BYSI."
What Stock Exchange Does BeyondSpring Inc Trade On?
BeyondSpring Inc is listed and trades on the NASDAQ stock exchange.
Is BeyondSpring Inc a Good Stock to Buy?
Determining whether BeyondSpring Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BYSI quote. (ISIN: KYG108301006) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the BeyondSpring Inc Stock Price Today?
The BeyondSpring Inc stock price today is 1.550.
What Is the Stock Symbol for BeyondSpring Inc?
The stock symbol for BeyondSpring Inc is "BYSI."
What Stock Exchange Does BeyondSpring Inc Trade On?
BeyondSpring Inc is listed and trades on the NASDAQ stock exchange.
Is BeyondSpring Inc a Good Stock to Buy?
Determining whether BeyondSpring Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BYSI quote. (ISIN: KYG108301006) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
Fair Value
An estimate of a BeyondSpring's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.490
1.615
52 wk Range
1.210
3.440
BYSI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a BeyondSpring's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.4901.615
52 wk Range
1.2103.440
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BYSI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a BeyondSpring's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 13G BEYONDSPRING INC. For: 13 February
- Investing.com
- Form 13G BEYONDSPRING INC. For: 13 February
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Earnings
Latest Release
Mar 25, 2026
EPS / Forecast
-0.06 / --
Revenue / Forecast
-- / --
Compare BYSI to Peers and Sector
Metrics to compare | BYSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBYSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.5x | −3.8x | −0.5x | |
PEG Ratio | −0.08 | −0.05 | 0.00 | |
Price/Book | −2.0x | 6.8x | 2.6x | |
Price / LTM Sales | - | 6.8x | 3.2x | |
Upside (Analyst Target) | - | 105.0% | 48.3% | |
Fair Value Upside | Unlock | −15.3% | 5.6% | Unlock |
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company’s lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia (CIN). It also develops Plinabulin in combination with Plinabulin+docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy and radiation; nivolumab, a PD-1 antibody that has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer (ES-SCLC); in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small-molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the BeyondSpring (BYSI) Stock Price Today?
The BeyondSpring stock price today is 1.550 USD.
What Stock Exchange Does BeyondSpring Trade On?
BeyondSpring is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for BeyondSpring?
The stock symbol for BeyondSpring is "BYSI."
What Is the BeyondSpring Market Cap?
As of today, BeyondSpring market cap is 63.740M USD.
What Is BeyondSpring's Earnings Per Share (TTM)?
The BeyondSpring EPS (TTM) is -0.210.
When Is the Next BeyondSpring Earnings Date?
BeyondSpring will release its next earnings report on Jun 17, 2026.
From a Technical Analysis Perspective, Is BYSI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has BeyondSpring Stock Split?
BeyondSpring has split 0 times.
How Many Employees Does BeyondSpring Have?
BeyondSpring has 44 employees.
What is the current trading status of BeyondSpring (BYSI)?
As of May 07, 2026, BeyondSpring (BYSI) is trading at a price of 1.550 USD, with a previous close of 1.440 USD. The stock has fluctuated within a day range of 1.490 USD to 1.615 USD, while its 52-week range spans from 1.210 USD to 3.440 USD.
What Is the BYSI Premarket Price?
BYSI's last pre-market stock price is 1.360 USD. The pre-market share volume is 490.000, and the stock has decreased by -0.080, or -5.560%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.